Efficacy of Short-course Blinatumomab for MRD Erradication in B-ALL — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Efficacy of Short-course Blinatumomab for MRD Erradication in B-ALL — Stella

Recruiting

Back to Acute Lymphoblastic Leukemia trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

Mexico

Hospital Universitario Dr. Jose E. Gonzalez, Monterrey, Nuevo León

Key details

Phase

Safety & dosing

Sponsor

Hospital Universitario Dr. Jose E. Gonzalez

Enrollment target

~30 participants

Started

January 2025

Primary completion

January 2027

Age range

16 Years – 60 Years

Last updated March 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov